In late 2019, drug maker, Sanofi, announced a voluntary recall of their over-the-counter (OTC) acid reflux medication, Zantac.
The recall was issued in part due to a U.S. Food and Drug Administration public statement that some ranitidine heartburn medications, including some products commonly known as Zantac, may contain unacceptable levels of Nitrosodimethylamine (NDMA).
NDMA is often used in research laboratories to induce cancer in rats and is classified as a known animal and probable human carcinogen.
According to USA Today, Zantac has been prescribed more than 15 million times a year for over a decade. Other common brands of ranitidine include:
If you or a loved one has been diagnosed with stomach cancer and you took Zantac OTC or another form of ranitidine for an extended period of time, you may be eligible to recover damages. Contact Allen, Allen, Allen and Allen, for a free case evaluation.
